Please login to the form below

psychiatric diseases

This page shows the latest psychiatric diseases news and features for those working in and with pharma, biotech and healthcare.

Novartis plans digital therapeutics for schizophrenia and MS

Jay Bradner, president of the Novartis Institutes for Biomedical Research, said: "Psychiatric and neurodegenerative diseases place a heavy physical, mental and economic burden on patients and their families. ... With widespread adoption of digital devices

Latest news

Boehringer crowdsources psychiatric research team

The team of neuroscientists was identified by Boehringer and BioMed X via a crowdsourcing competition tasked with exploring the 'most promising solution approaches' to psychiatric diseases. ... Last year, Boehringer Ingelheim entered into a psychiatric
Boehringer pledges €11bn to fund R&D drive

All four collaborations are focusing on research into inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, looking at new therapeutic targets as well as biomarkers that can be ... In addition, the company signed a deal with Circuit
John Thievon named president of Dey Pharma

As president of Dey Pharma, Thievon will drive the company's focus on medicines to treat respiratory diseases, severe allergic reactions and psychiatric disorders.
GSK/Neurocrine depression drug fails

Neurocrine and GSK signed a worldwide research, development and commercialisation agreement for Corticotropin Releasing Factor Receptor Antagonists for psychiatric, neurological and gastrointestinal diseases in 2001.
First Irish genome sequencing lab opens

Ireland's first Genome Sequencing Laboratory will enable research into psychiatric disorders, infectious diseases, disorders of the immune system and other human diseases.

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

Deal Watch January 2016

Product portfolio covering rare diseases in haematology, immunology, oncology; cash and stock deal at 37.5% share price premium. ... diseases and other indications targeting an undisclosed orphan G protein–coupled receptor (GPCR) . 262. Dual

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Sanofi appoints Diane Souza and Thomas Südhof

Before joining Stanford, he spent 25 years at the University of Texas as chairman of the department of neuroscience researching neuro-degenerative and neuro-psychiatric diseases.
MedDay appoints former Sanofi VP to board

Goupit said: “I strongly believe that MedDay's product pipeline and its research platform, SPECMET, could have a major impact on the treatment of neurological and psychiatric diseases.”.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

Diagnosing the lag in neuropsychiatric treatments

This means that while successful drugs for psychiatric diseases have been introduced into the market, subsequent new drugs are based on similar mechanisms of actions or therapeutic targets. ... The answer is simple, while bacterial and viral infections
emotive. expands Medical Writing and Client Services teams

With over 9 years’ experience in medical communications, Aki Okazaki who is joining as an Associate Director, has worked in a broad range of therapeutic areas including haematology, infectious diseases, oncology, ... psychiatric conditions, rare

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Account Director, Medical Communications & Events: £50 - 65, 000 according to skills and experience benefits

Account Director or Senior Account Director: Salary TBC

Director of Scientific Services, Medical Communications, Six fig...: Six figure salary

Senior Medical Writer, MedComms Agency: Salary TBC

Vice President: Competitive Salary Offered

Principal Medical Writer: £48 - 58, 000 according to skills and experience benefits

Consultant: competitive salary

Account Manager– Medical Communications: (Negotiable - depending on experience)

Subscribe to our email news alerts

PMHub

Add my company

Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

How do companies prepare for reimbursement?: Valid Insight explore how to optimise your market access strategy during new product development, how to address payer concerns and prepare for reimbursement....
Integrating electronic health records into clinical trials: How organisations are working to realise the research potential of EHRs...
Keeping up the fight against HIV and using the lessons to tackle other threats: Danny Buckland interviews Gilead’s Mike Elliott...